AGENT FOR TREATING MYOPIA, PREVENTING MYOPIA AND/OR SUPPRESSING MYOPIA PROGRESSION
The present invention relates to a pharmaceutical composition for treating myopia, preventing myopia and/or suppressing myopia progression, comprising (+)-11-[2-[2-[(diethylamino)methyl]-1-piperidinyl]acetyl]-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one or a salt thereof as an active ingred...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | INABA, Takaaki KATO, Masatomo |
| description | The present invention relates to a pharmaceutical composition for treating myopia, preventing myopia and/or suppressing myopia progression, comprising (+)-11-[2-[2-[(diethylamino)methyl]-1-piperidinyl]acetyl]-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one or a salt thereof as an active ingredient, wherein the pharmaceutical composition is substantially free of (-)-11-[2-[2-[(diethylamino)methyl]-1-piperidinyl]acetyl]-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one or a salt thereof.
La présente invention concerne une composition pharmaceutique pour traiter la myopie, prévenir la myopie et/ou entraver la progression de la myopie, comprenant (+)-11-[2-[2-[(diéthylamino)méthyl]-1-pipéridinyl]acétyl]-5,11-dihydro-6H-pyrido[2,3-b] [1,4] benzodiazépin-6-one ou un sel de celui-ci en tant que principe actif, la composition pharmaceutique étant sensiblement exempte de (-)-11-[2-[2-[(diéthylamino)méthyl]-1-pipéridinyl]acétyl]-5,11-dihydro-6H-pyrido [2,3-b] [1,4] benzodiazépin-6-one ou un sel de celui-ci. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2022030489A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2022030489A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2022030489A13</originalsourceid><addsrcrecordid>eNrjZAhydHf1C1Fw8w9SCAlydQzx9HNX8I30D_B01FEICHINA0oihBQc_Vz0gSqDQwOAcsHBSDIBQf7uYCF_Px4G1rTEnOJUXijNzaDs5hri7KGbWpAfn1pckJicmpdaEh_ub2RgZGRgbGBiYeloaEycKgC-FjD1</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>AGENT FOR TREATING MYOPIA, PREVENTING MYOPIA AND/OR SUPPRESSING MYOPIA PROGRESSION</title><source>esp@cenet</source><creator>INABA, Takaaki ; KATO, Masatomo</creator><creatorcontrib>INABA, Takaaki ; KATO, Masatomo</creatorcontrib><description>The present invention relates to a pharmaceutical composition for treating myopia, preventing myopia and/or suppressing myopia progression, comprising (+)-11-[2-[2-[(diethylamino)methyl]-1-piperidinyl]acetyl]-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one or a salt thereof as an active ingredient, wherein the pharmaceutical composition is substantially free of (-)-11-[2-[2-[(diethylamino)methyl]-1-piperidinyl]acetyl]-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one or a salt thereof.
La présente invention concerne une composition pharmaceutique pour traiter la myopie, prévenir la myopie et/ou entraver la progression de la myopie, comprenant (+)-11-[2-[2-[(diéthylamino)méthyl]-1-pipéridinyl]acétyl]-5,11-dihydro-6H-pyrido[2,3-b] [1,4] benzodiazépin-6-one ou un sel de celui-ci en tant que principe actif, la composition pharmaceutique étant sensiblement exempte de (-)-11-[2-[2-[(diéthylamino)méthyl]-1-pipéridinyl]acétyl]-5,11-dihydro-6H-pyrido [2,3-b] [1,4] benzodiazépin-6-one ou un sel de celui-ci.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220210&DB=EPODOC&CC=WO&NR=2022030489A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220210&DB=EPODOC&CC=WO&NR=2022030489A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>INABA, Takaaki</creatorcontrib><creatorcontrib>KATO, Masatomo</creatorcontrib><title>AGENT FOR TREATING MYOPIA, PREVENTING MYOPIA AND/OR SUPPRESSING MYOPIA PROGRESSION</title><description>The present invention relates to a pharmaceutical composition for treating myopia, preventing myopia and/or suppressing myopia progression, comprising (+)-11-[2-[2-[(diethylamino)methyl]-1-piperidinyl]acetyl]-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one or a salt thereof as an active ingredient, wherein the pharmaceutical composition is substantially free of (-)-11-[2-[2-[(diethylamino)methyl]-1-piperidinyl]acetyl]-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one or a salt thereof.
La présente invention concerne une composition pharmaceutique pour traiter la myopie, prévenir la myopie et/ou entraver la progression de la myopie, comprenant (+)-11-[2-[2-[(diéthylamino)méthyl]-1-pipéridinyl]acétyl]-5,11-dihydro-6H-pyrido[2,3-b] [1,4] benzodiazépin-6-one ou un sel de celui-ci en tant que principe actif, la composition pharmaceutique étant sensiblement exempte de (-)-11-[2-[2-[(diéthylamino)méthyl]-1-pipéridinyl]acétyl]-5,11-dihydro-6H-pyrido [2,3-b] [1,4] benzodiazépin-6-one ou un sel de celui-ci.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZAhydHf1C1Fw8w9SCAlydQzx9HNX8I30D_B01FEICHINA0oihBQc_Vz0gSqDQwOAcsHBSDIBQf7uYCF_Px4G1rTEnOJUXijNzaDs5hri7KGbWpAfn1pckJicmpdaEh_ub2RgZGRgbGBiYeloaEycKgC-FjD1</recordid><startdate>20220210</startdate><enddate>20220210</enddate><creator>INABA, Takaaki</creator><creator>KATO, Masatomo</creator><scope>EVB</scope></search><sort><creationdate>20220210</creationdate><title>AGENT FOR TREATING MYOPIA, PREVENTING MYOPIA AND/OR SUPPRESSING MYOPIA PROGRESSION</title><author>INABA, Takaaki ; KATO, Masatomo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2022030489A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2022</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>INABA, Takaaki</creatorcontrib><creatorcontrib>KATO, Masatomo</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>INABA, Takaaki</au><au>KATO, Masatomo</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>AGENT FOR TREATING MYOPIA, PREVENTING MYOPIA AND/OR SUPPRESSING MYOPIA PROGRESSION</title><date>2022-02-10</date><risdate>2022</risdate><abstract>The present invention relates to a pharmaceutical composition for treating myopia, preventing myopia and/or suppressing myopia progression, comprising (+)-11-[2-[2-[(diethylamino)methyl]-1-piperidinyl]acetyl]-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one or a salt thereof as an active ingredient, wherein the pharmaceutical composition is substantially free of (-)-11-[2-[2-[(diethylamino)methyl]-1-piperidinyl]acetyl]-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one or a salt thereof.
La présente invention concerne une composition pharmaceutique pour traiter la myopie, prévenir la myopie et/ou entraver la progression de la myopie, comprenant (+)-11-[2-[2-[(diéthylamino)méthyl]-1-pipéridinyl]acétyl]-5,11-dihydro-6H-pyrido[2,3-b] [1,4] benzodiazépin-6-one ou un sel de celui-ci en tant que principe actif, la composition pharmaceutique étant sensiblement exempte de (-)-11-[2-[2-[(diéthylamino)méthyl]-1-pipéridinyl]acétyl]-5,11-dihydro-6H-pyrido [2,3-b] [1,4] benzodiazépin-6-one ou un sel de celui-ci.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2022030489A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | AGENT FOR TREATING MYOPIA, PREVENTING MYOPIA AND/OR SUPPRESSING MYOPIA PROGRESSION |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T19%3A06%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=INABA,%20Takaaki&rft.date=2022-02-10&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2022030489A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |